Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety
Public ClinicalTrials.gov record NCT02878928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multi-Center, Randomized Clinical Study to Evaluate the Clinical Impact of Pharmacogenetic-Guided Treatment for Depression & Anxiety
Study identification
- NCT ID
- NCT02878928
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- AltheaDx
- Industry
- Enrollment
- 579 participants
Conditions and interventions
Conditions
Interventions
- IDgenetix Neuropsychiatric Test Panel Genetic
Genetic
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2016
- Primary completion
- Nov 30, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Dec 18, 2016
2016
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adnab Research | Rolling Hills | California | — | — |
| Artemis Clinical Research | San Diego | California | — | — |
| Adnab Research | Torrance | California | — | — |
| Collaborative Neuroscience Network | Torrance | California | — | — |
| Innovative Clinical Research | Lauderhill | Florida | — | — |
| Innova Clinical Trials | Miami | Florida | — | — |
| APG Research | Orlando | Florida | — | — |
| iResearch Atlanta | Decatur | Georgia | — | — |
| Meridian Clinical Research | Savannah | Georgia | — | — |
| Medpharmics | Metairie | Louisiana | — | — |
| Meridian Clinical Research | Norfolk | Nebraska | — | — |
| United Medical Associates | Binghamton | New York | — | — |
| Richmond Behavioral Associates | Staten Island | New York | — | — |
| Carolina Partners in Mental HealthCare | Raleigh | North Carolina | — | — |
| Detweiler Family Medicine | Lansdale | Pennsylvania | — | — |
| Relaro Medical Trials | Dallas | Texas | — | — |
| Tidewater Clinical Research | Virginia Beach | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02878928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2016 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02878928 live on ClinicalTrials.gov.